Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Ying‑Fen Hong"'
Autor:
Qi Zhang, Dong-Hao Wu, Xiang-Yuan Wu, Ying-fen Hong, Hui-qiang Huang, Zhan-Hong Chen, Chang-Chang Jia, Tian-Tian Wang, Yang Li
Publikováno v:
Biochemical and Biophysical Research Communications. 558:14-21
Sorafenib remains the standard first-line treatment for advanced hepatocellular carcinoma (HCC), although other clinical trials are currently underway for treatments that show better curative effects. However, some patients are not sensitive to soraf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b06422124bd937a6545abfeaa0a42e81
https://doi.org/10.1016/j.bbrc.2021.04.047
https://doi.org/10.1016/j.bbrc.2021.04.047
Autor:
YING-FEN HONG1, ZHAN-HONG CHEN1,2 sumszhanhong@163.com, LI WEI1, XIAO-KUN MA1, XING LI1, JING-YUN WEN1, TIAN-TIAN WANG1, XIU-RONG CAI1, DONG-HAO WU1, JIE CHEN1, DAN-YUN RUAN1, ZE-XIAO LIN1, QU LIN1, MIN DONG1, XIANG-YUAN WU1 wuxiangy@mail.sysu.edu.cn
Publikováno v:
Oncology Letters. Aug2017, Vol. 14 Issue 2, p2089-2096. 8p.
Autor:
YING‑FEN HONG1, JINXIANG LIN1, XING LI1, DONG‑HAO WU1, JING‑YUN WEN1, JIE CHEN1, DAN‑YUN RUAN1, QU LIN1, MIN DONG1, LI WEI1, TIAN‑TIAN WANG1, ZE‑XIAO LIN1, XIAO‑KUN MA1, XIANG‑YUAN WU1, ZHAN‑HONG CHEN1,2, RUIHUA XU2
Publikováno v:
Oncology Letters. Jul2017, Vol. 14 Issue 1, p704-714. 11p. 5 Charts, 9 Graphs.
Autor:
Dan‑Yun Ruan, Jing Yun Wen, Ze‑Xiao Lin, Ying‑Fen Hong, Jie Chen, Zhan Hong Chen, Xing Li, Li Wei, Tian-Tian Wang, Xiao Kun Ma, Qu Lin, Xiang Yuan Wu, Min Dong, Xiu Rong Cai, Dong‑Hao Wu
Publikováno v:
Oncology Letters
The inflammatory microenvironment serves an important function in the progression of hepatocellular carcinoma (HCC). Peripheral blood lymphocyte-to-monocyte ratio (LMR), as a novel inflammatory biomarker combining an estimate of host immune homeostas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f2043cd264f636819dcac3348d08f53
http://europepmc.org/articles/PMC5530031
http://europepmc.org/articles/PMC5530031
Autor:
Ze‑Xiao Lin, Jie Chen, Jing Yun Wen, Rui-Hua Xu, Li Wei, Qu Lin, Dong‑Hao Wu, Xiao Kun Ma, Jin-Xiang Lin, Min Dong, Xiang Yuan Wu, Tian-Tian Wang, Xing Li, Dan‑Yun Ruan, Zhan Hong Chen, Ying‑Fen Hong
Publikováno v:
Oncology Letters
The aim of the present study was to evaluate the ability of seven staging systems to predict 3- and 6-month and cumulative survival rates of patients with advanced hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC). Data were collected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::954764d1aa81f6e810078adda6e7cb00
https://doi.org/10.3892/ol.2017.6222
https://doi.org/10.3892/ol.2017.6222
Autor:
Jie Zhou, Ai-Hua Lei, Xiang-Yuan Wu, Zhi-Huan Lin, Xing Li, Yan-Fang Xing, Qiang Xiao, Ying-Fen Hong
Publikováno v:
Oncotarget
// Xing Li 1, 2, 3 , Yan-Fang Xing 4 , Ai-Hua Lei 1, 2 , Qiang Xiao 1, 2 , Zhi-Huan Lin 3 , Ying-Fen Hong 3 , Xiang-Yuan Wu 3 , Jie Zhou 1, 2 1 Program in Immunology, Affiliated Guangzhou Women and Children’s Medical Center, Zhongshan School of Med
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::440e89b0c56543a803351e8b7a95dbd3
https://doi.org/10.18632/oncotarget.15456
https://doi.org/10.18632/oncotarget.15456
Autor:
Li Wei, Xiang-Wei Chen, Jing Yun Wen, Dan‑Yun Ruan, Tian-Tian Wang, Ying‑Fen Hong, Rui-Hua Xu, Ze‑Xiao Lin, Xing Li, Dong‑Hao Wu, Min Dong, Jie Chen, Jin-Xiang Lin, Xiao Kun Ma, Qu Lin, Zhan Hong Chen, Xiang Yuan Wu
Publikováno v:
Oncology Letters
The majority of patients with unresectable hepatocellular carcinoma (HCC) undergo trans-arterial chemoembolization (TACE). However, the prognosis of HCC remains poor. In the present study, five staging systems were compared to predict the survival ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f8129c4ed6375bc2b4128423b31e285
https://doi.org/10.3892/ol.2017.7419
https://doi.org/10.3892/ol.2017.7419
Autor:
Xiang-Yuan Wu, Xiu-Rong Cai, Xing Li, Zhan-Hong Chen, Chang-Chang Jia, Qu Lin, Min Dong, Tian-Tian Wang, Jin-Xiang Lin, Ying-Fen Hong
Publikováno v:
Oncotarget
// Xiu-Rong Cai 1, 2, * , Xing Li 1, 2, * , Jin-Xiang Lin 1 , Tian-Tian Wang 1, 2 , Min Dong 1, 2 , Zhan-Hong Chen 1, 2 , Chang-Chang Jia 2, 3 , Ying-Fen Hong 1, 2 , Qu Lin 1, 2 and Xiang-Yuan Wu 1, 2 1 Department of Medical Oncology, the Third Affil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::806c0b3f71a0d46d2e562a8ba678cf8e
https://pubmed.ncbi.nlm.nih.gov/28412743
https://pubmed.ncbi.nlm.nih.gov/28412743
Autor:
Zhan-Hong Chen, Jie Chen, Qu Lin, Ying-Fen Hong, Ze-Xiao Lin, Jing-Yun Wen, Min Dong, Xiang-Yuan Wu, Dong-Hao Wu, Xing Li, Chang-Chang Jia, Xiao-Kun Ma, Tian-Tian Wang, Li Wei, Dan-Yun Ruan
Publikováno v:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 37(4)
Prognosis of patients with advanced hepatocellular carcinoma (HCC) is under expectation. Life expectancy more than 3 months is one inclusion criteria for molecular targeted drugs in clinical trials. The main purpose of this research is to compare Mod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45cd0e523b0a19889dd1bae95563ab3e
https://pubmed.ncbi.nlm.nih.gov/26561464
https://pubmed.ncbi.nlm.nih.gov/26561464
Autor:
Jing-Yun Wen, Ze-Xiao Lin, Qu Lin, Zhi-Huan Lin, Xing Li, Yan-Fang Xing, Xiang-Yuan Wu, Li Wei, Jie Chen, Xiang Zhong, Zhan-Hong Chen, Xiao-Kun Ma, Dong-Hao Wu, Dan-Yun Ruan, Mingsheng Huang, Tian-Tian Wang, Ying-Fen Hong, Min Dong
Publikováno v:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 37(3)
The prognosis of hepatocellular carcinoma (HCC) patients receiving transcatheter arterial chemoembolization (TACE) is far from being identified. The present study aimed to assess the role of blood cell counts, routine liver function tests, and alanin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f623a75326fb17a1415a2a51ad9739d7
https://pubmed.ncbi.nlm.nih.gov/26411670
https://pubmed.ncbi.nlm.nih.gov/26411670